CN101612243A - 一种天然植物花椒提取物的应用方法 - Google Patents
一种天然植物花椒提取物的应用方法 Download PDFInfo
- Publication number
- CN101612243A CN101612243A CN200910055788A CN200910055788A CN101612243A CN 101612243 A CN101612243 A CN 101612243A CN 200910055788 A CN200910055788 A CN 200910055788A CN 200910055788 A CN200910055788 A CN 200910055788A CN 101612243 A CN101612243 A CN 101612243A
- Authority
- CN
- China
- Prior art keywords
- extract
- natural plant
- application process
- plant pepper
- eluant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- 241000196324 Embryophyta Species 0.000 title claims abstract description 21
- 229940116257 pepper extract Drugs 0.000 title claims abstract description 21
- 230000008569 process Effects 0.000 title claims abstract description 19
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims abstract description 90
- 239000003814 drug Substances 0.000 claims abstract description 50
- 229960001340 histamine Drugs 0.000 claims abstract description 45
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 235000013402 health food Nutrition 0.000 claims abstract description 8
- 230000003266 anti-allergic effect Effects 0.000 claims abstract description 7
- 230000001139 anti-pruritic effect Effects 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 127
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- 241000722363 Piper Species 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 238000000605 extraction Methods 0.000 claims description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- 239000007864 aqueous solution Substances 0.000 claims description 25
- 239000002904 solvent Substances 0.000 claims description 21
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 18
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 15
- 239000001569 carbon dioxide Substances 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 11
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 7
- -1 under 20-100 °C Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000003208 petroleum Substances 0.000 claims description 6
- 238000000638 solvent extraction Methods 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 4
- 238000001256 steam distillation Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 3
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- 210000003630 histaminocyte Anatomy 0.000 abstract description 11
- 239000011347 resin Substances 0.000 description 30
- 229920005989 resin Polymers 0.000 description 30
- BQFCCCIRTOLPEF-UHFFFAOYSA-N chembl1976978 Chemical compound CC1=CC=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 BQFCCCIRTOLPEF-UHFFFAOYSA-N 0.000 description 24
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 22
- 229940079593 drug Drugs 0.000 description 19
- 238000010298 pulverizing process Methods 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 18
- 238000010521 absorption reaction Methods 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 208000003251 Pruritus Diseases 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000008367 deionised water Substances 0.000 description 12
- 229910021641 deionized water Inorganic materials 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001387 anti-histamine Effects 0.000 description 6
- 239000000739 antihistaminic agent Substances 0.000 description 6
- LLEJIEBFSOEYIV-UHFFFAOYSA-N chelerythrine Chemical compound C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 4
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- KOFVUVJGUULEKJ-UHFFFAOYSA-N Schinifoline + Natural products COC1=C(C=CC(=C)C)C(=O)Nc2ccccc12 KOFVUVJGUULEKJ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- SLSIBLKBHNKZTB-UHFFFAOYSA-N Skimmianine Chemical compound COC1=C2C=COC2=NC2=C(OC)C(OC)=CC=C21 SLSIBLKBHNKZTB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960002045 bergapten Drugs 0.000 description 2
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920002055 compound 48/80 Polymers 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 108091008708 free nerve endings Proteins 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- KOFVUVJGUULEKJ-CMDGGOBGSA-N schinifoline Chemical compound C1=CC=C2C(OC)=C(\C=C\C(C)=C)C(=O)NC2=C1 KOFVUVJGUULEKJ-CMDGGOBGSA-N 0.000 description 2
- HCUSLQJBGQJQCB-UHFFFAOYSA-N schinifoline Natural products C1=CC=C2N(C)C(CCCCCCC)=CC(=O)C2=C1 HCUSLQJBGQJQCB-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 2
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 2
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 2
- GOCCREQJUBABAL-UHFFFAOYSA-N 2,2-dihydroxyacetic acid Chemical compound OC(O)C(O)=O GOCCREQJUBABAL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000003330 peritoneal dialysis fluid Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000003900 secondary neuron Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000003009 spinothalamic tract Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100557885A CN101612243B (zh) | 2009-07-31 | 2009-07-31 | 一种天然植物花椒提取物在制备抑制组胺释放的药物、化妆品及保健食品中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100557885A CN101612243B (zh) | 2009-07-31 | 2009-07-31 | 一种天然植物花椒提取物在制备抑制组胺释放的药物、化妆品及保健食品中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101612243A true CN101612243A (zh) | 2009-12-30 |
CN101612243B CN101612243B (zh) | 2012-07-18 |
Family
ID=41492251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100557885A Active CN101612243B (zh) | 2009-07-31 | 2009-07-31 | 一种天然植物花椒提取物在制备抑制组胺释放的药物、化妆品及保健食品中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101612243B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949506A (zh) * | 2012-05-08 | 2013-03-06 | 上海莱博生物科技有限公司 | 止痒抗过敏的中药提取物及制备方法、应用和药物组合物 |
CN103099163A (zh) * | 2011-11-14 | 2013-05-15 | 长谷川香料株式会社 | 含羟基山椒素的提取物的制造方法 |
CN104030937A (zh) * | 2014-06-16 | 2014-09-10 | 中华全国供销合作总社南京野生植物综合利用研究所 | 一种快速制备高含量花椒不饱和酰胺类成分的方法 |
CN105533618A (zh) * | 2014-10-27 | 2016-05-04 | 小川香料株式会社 | 利用花椒提取物的高甜度甜味料的呈味改善剂 |
CN107354008A (zh) * | 2017-05-16 | 2017-11-17 | 晨光生物科技集团股份有限公司 | 一种高品质花椒提取物的制备方法 |
CN107488514A (zh) * | 2017-09-27 | 2017-12-19 | 四川帅青花椒开发有限公司 | 一种超临界co2萃取青花椒树脂工艺 |
CN108685804A (zh) * | 2018-08-14 | 2018-10-23 | 威宁县农景种植专业合作社 | 一种花椒洗发水的制备方法 |
CN109771503A (zh) * | 2017-11-15 | 2019-05-21 | 中国医学科学院药用植物研究所 | 一种花椒提取物及其应用 |
CN110511631A (zh) * | 2019-09-18 | 2019-11-29 | 上海源育节能环保科技有限公司 | 一种健康环保涂料及其制备方法 |
CN110575413A (zh) * | 2019-10-24 | 2019-12-17 | 山东花物堂生物科技有限公司 | 一种花椒提取物的制备方法及其在化妆品的应用 |
-
2009
- 2009-07-31 CN CN2009100557885A patent/CN101612243B/zh active Active
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103099163A (zh) * | 2011-11-14 | 2013-05-15 | 长谷川香料株式会社 | 含羟基山椒素的提取物的制造方法 |
JP2013103901A (ja) * | 2011-11-14 | 2013-05-30 | T Hasegawa Co Ltd | ヒドロキシサンショオール含有物の製造方法 |
CN102949506A (zh) * | 2012-05-08 | 2013-03-06 | 上海莱博生物科技有限公司 | 止痒抗过敏的中药提取物及制备方法、应用和药物组合物 |
CN104030937A (zh) * | 2014-06-16 | 2014-09-10 | 中华全国供销合作总社南京野生植物综合利用研究所 | 一种快速制备高含量花椒不饱和酰胺类成分的方法 |
CN105533618A (zh) * | 2014-10-27 | 2016-05-04 | 小川香料株式会社 | 利用花椒提取物的高甜度甜味料的呈味改善剂 |
CN105533618B (zh) * | 2014-10-27 | 2017-04-12 | 小川香料株式会社 | 利用花椒提取物的高甜度甜味料的呈味改善方法 |
CN107354008A (zh) * | 2017-05-16 | 2017-11-17 | 晨光生物科技集团股份有限公司 | 一种高品质花椒提取物的制备方法 |
CN107488514A (zh) * | 2017-09-27 | 2017-12-19 | 四川帅青花椒开发有限公司 | 一种超临界co2萃取青花椒树脂工艺 |
CN107488514B (zh) * | 2017-09-27 | 2021-03-30 | 四川帅青花椒开发有限公司 | 一种超临界co2萃取青花椒树脂工艺 |
CN109771503A (zh) * | 2017-11-15 | 2019-05-21 | 中国医学科学院药用植物研究所 | 一种花椒提取物及其应用 |
CN109771503B (zh) * | 2017-11-15 | 2021-10-22 | 中国医学科学院药用植物研究所 | 一种花椒提取物及其应用 |
CN108685804A (zh) * | 2018-08-14 | 2018-10-23 | 威宁县农景种植专业合作社 | 一种花椒洗发水的制备方法 |
CN110511631A (zh) * | 2019-09-18 | 2019-11-29 | 上海源育节能环保科技有限公司 | 一种健康环保涂料及其制备方法 |
CN110575413A (zh) * | 2019-10-24 | 2019-12-17 | 山东花物堂生物科技有限公司 | 一种花椒提取物的制备方法及其在化妆品的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101612243B (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101612243B (zh) | 一种天然植物花椒提取物在制备抑制组胺释放的药物、化妆品及保健食品中的用途 | |
CN101612212A (zh) | 一种天然植物芍药提取物的应用方法 | |
CN102212093A (zh) | 黄酮苷类化合物及其制备方法和用途 | |
CN101474350B (zh) | 芦笋总皂苷的提取方法及其应用 | |
CN101612292A (zh) | 一种天然植物土茯苓提取物的应用方法 | |
CN103263450A (zh) | 中药组合物 | |
CN102988764B (zh) | 一种抗鸡球虫的中药制剂及其制备方法 | |
CN105796961A (zh) | 陈皮和白茅根组合物在制备抗化疗呕吐药物中的用途 | |
CN103202898B (zh) | 中药组合物及其制备方法 | |
CN105030855B (zh) | 一种防治心血管疾病、高血脂症保健茶及其制备方法和检测方法 | |
CN103301377A (zh) | 天然药物组合物 | |
CN103263491A (zh) | 中药组合物 | |
CN105168519B (zh) | 具有改善睡眠功能的组合物及其制备方法和应用 | |
CN103263492A (zh) | 中药提取物 | |
CN103263475A (zh) | 中药组合物 | |
CN103251771A (zh) | 中药组合物 | |
CN103223085A (zh) | 中药提取物 | |
CN103230456A (zh) | 一种中药提取物及其制备方法 | |
CN103202886A (zh) | 中药组合物及其制备方法 | |
CN107260773B (zh) | 腊梅属植物抗疱疹病毒的用途 | |
CN106188083A (zh) | 一种从艾叶中提取1,8‑桉叶素挥发油的方法 | |
CN103251660A (zh) | 中药组合物 | |
CN103263541A (zh) | 中药提取物及其制备方法 | |
CN103316189A (zh) | 天然药物组合物 | |
CN103263474A (zh) | 一种中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200240 Shanghai city Minhang District Jianchuan Road No. 951 building 4 room 435 Patentee after: Shanghai Rulaipei Bio-chemical Co., Ltd. Patentee after: Laibo Industrial (Shanghai) Limited by Share Ltd Patentee after: Shanghai Laige Bio-chemical Co., Ltd. Patentee after: Shanghai Laipusen Bio-chemical Co., Ltd. Patentee after: Shanghai Kouman Bio-chemical Co., Ltd. Address before: 200240 Shanghai city Minhang District Jianchuan Road No. 951 building 4 room 435 Patentee before: Shanghai Rulaipei Bio-chemical Co., Ltd. Patentee before: Shanghai Laibo Bio-chemical Co., Ltd. Patentee before: Shanghai Laige Bio-chemical Co., Ltd. Patentee before: Shanghai Laipusen Bio-chemical Co., Ltd. Patentee before: Shanghai Kouman Bio-chemical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200240 Shanghai city Minhang District Jianchuan Road No. 951 building 4 room 435 Co-patentee after: Laibo cosmeceutical Technology (Shanghai) Limited by Share Ltd Patentee after: Bond (Shanghai) Cosmetics Co., Ltd. Co-patentee after: Shanghai Laige Bio-chemical Co., Ltd. Co-patentee after: Shanghai Laipusen Bio-chemical Co., Ltd. Co-patentee after: Shanghai Kouman Bio-chemical Co., Ltd. Address before: 200240 Shanghai city Minhang District Jianchuan Road No. 951 building 4 room 435 Co-patentee before: Laibo Industrial (Shanghai) Limited by Share Ltd Patentee before: Shanghai Rulaipei Bio-chemical Co., Ltd. Co-patentee before: Shanghai Laige Bio-chemical Co., Ltd. Co-patentee before: Shanghai Laipusen Bio-chemical Co., Ltd. Co-patentee before: Shanghai Kouman Bio-chemical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190311 Address after: 8th Floor, Building No. 1, 333 Guiping Road, Xuhui District, Shanghai, 2003 Patentee after: Laibo cosmeceutical Technology (Shanghai) Limited by Share Ltd Address before: Room 435, Building 4, 951 Jianchuan Road, Minhang District, Shanghai, 200240 Co-patentee before: Laibo cosmeceutical Technology (Shanghai) Limited by Share Ltd Patentee before: Bond (Shanghai) Cosmetics Co., Ltd. Co-patentee before: Shanghai Laige Bio-chemical Co., Ltd. Co-patentee before: Shanghai Laipusen Bio-chemical Co., Ltd. Co-patentee before: Shanghai Kouman Bio-chemical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220208 Address after: 201401 building 4, No. 1979, CHENQiao Road, Fengxian District, Shanghai Patentee after: Shengwei Pharmaceutical (Shanghai) Co.,Ltd. Address before: 8th Floor, Building No. 1, 333 Guiping Road, Xuhui District, Shanghai, 2003 Patentee before: LB COSMECEUTICAL TECHNOLOGY Co.,Ltd. |